1. Savely VR, Leitao MM, Stricker RB. The mystery of Morgellons disease: infection or delusion? Am J Clin Dermatol. 2006; 7:1–5.
2. Pearson ML, Selby JV, Katz KA, Cantrell V, Braden CR, Parise ME, et al. Clinical, epidemiologic, histopathologic and molecular features of an unexplained dermopathy. PLoS One. 2012; 7:e29908.
Article
3. Middelveen MJ, Bandoski C, Burke J, Sapi E, Filush KR, Wang Y, et al. Exploring the association between Morgellons disease and Lyme disease: identification of Borrelia burgdorferi in Morgellons disease patients. BMC Dermatol. 2015; 15:1.
Article
4. Middelveen MJ, Burugu D, Poruri A, Burke J, Mayne PJ, Sapi E, et al. Association of spirochetal infection with Morgellons disease. F1000Re. 2013; 2:25.
Article
5. Robles DT, Olson JM, Combs H, Romm S, Kirby P. Morgellons disease and delusions of parasitosis. Am J Clin Dermatol. 2011; 12:1–6.
Article
6. Söderfeldt Y, Groß D. Information, consent and treatment of patients with Morgellons disease: an ethical perspective. Am J Clin Dermatol. 2014; 15:71–76.
Article
7. Hylwa SA, Foster AA, Bury JE, Davis MD, Pittelkow MR, Bostwick JM. Delusional infestation is typically comorbid with other psychiatric diagnoses: review of 54 patients receiving psychiatric evaluation at Mayo Clinic. Psychosomatics. 2012; 53:258–265.
Article
8. Foster AA, Hylwa SA, Bury JE, Davis MD, Pittelkow MR, Bostwick JM. Delusional infestation: clinical presentation in 147 patients seen at Mayo Clinic. J Am Acad Dermatol. 2012; 67:673.e1–673.e10.
Article
9. Gartner AM, Dolan SL, Stanford MS, Elkins GR. Hypnosis in the treatment of Morgellons disease: a case study. Int J Clin Exp Hypn. 2011; 59:242–249.
10. Reid EE, Lio PA. Successful treatment of Morgellons disease with pimozide therapy. Arch Dermatol. 2010; 146:1191–1193.
Article
11. Middelveen MJ, Mayne PJ, Kahn DG, Stricker RB. Characterization and evolution of dermal filaments from patients with Morgellons disease. Clin Cosmet Investig Dermatol. 2013; 6:1–21.